Published 09/19/2024 12:09:04 a.m.

New treatments for migraine … and other research

Summary by Dataemia

Tom Nolan’s research review in the BMJ corrected a mistake about the classification of drugs semaglutide and liraglutide as GLP-1 receptor antagonists. The correct classification is GLP-1 receptor agonists. The correction was made to the article published on September 12, 2024. Source link

0 Articles

0 Articles

All

Left

Center

Right

New treatments for migraine … and other research

Tom Nolan’s research review in the BMJ corrected a mistake about the classification of drugs semaglutide and liraglutide as GLP-1 receptor antagonists. The correct classification is GLP-1 receptor agonists. The correction was made to the article published on September 12, 2024. Source link

09/19/2024 12:09:04 a.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/19/2024 1:19:38 a.m.Bias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc